Who
Jacob Steven Leach
President, CEO, and Director
Company insider
Files Form 4 as: President, CEO, and Director, DexCom; Director, SenesTech.
In numbers
- Trades disclosed
- 125
- Buys
- 4
- Sells
- 28
- Bought
- $1.2M
- Sold
- $53.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 Mar 2017
- Last trade
- 22 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Aug 2026filed 25 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $134K1,451 at $92.34 | filing |
| 22 Aug 2026filed 25 Aug 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $134K1,451 at $92.34 | filing |
| 15 Jun 2026filed 17 Jun 2026 | SNES SenesTechoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | SNES SenesTechoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $104K1,451 at $71.90 | filing |
| 22 May 2026filed 27 May 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $104K1,451 at $71.90 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —104,516 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $1.3M19,757 at $68.10 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —104,516 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $1.3M19,757 at $68.10 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —8,310 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $224K3,058 at $73.36 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —8,310 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code F | $224K3,058 at $73.36 | filing |
| 18 Nov 2025filed 19 Nov 2025 | SNES SenesTechAgricultural Chemicals & Fertilizers | SEC FORM 4 Sold | $16862 at $2.71 | filing |
| 10 Nov 2025filed 10 Nov 2025 | DXCM DexComMedical Devices | SEC FORM 4 Bought | $863K15,700 at $54.98 | filing |
| 10 Nov 2025filed 10 Nov 2025 | DXCM DexComMedical Devices | SEC FORM 4 Bought | $139K2,500 at $55.43 | filing |
| 12 Mar 2025filed 14 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Sold | $991K14,076 at $70.38 | filing |
| 8 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —35,906 at $0.00 | filing |
| 8 Mar 2025filed 11 Mar 2025 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —22,798 at $0.00 | filing |
News
SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential GrowthSNES · finanznachrichten.de · 15 Oct 2026DexCom, Inc. $DXCM Position Lowered by Gradient Investments LLCDXCM · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Jacob Steven Leach; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.